Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2013

Oct 2, 2013

32853_dirs_2013-10-02_cd7786a6-960c-430a-ba32-a8214e003249.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-09-30

Reporting Person: JONES ROBERT C (EVP, RESEARCH & DEVELOPMENT)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-30 Common Stock M 1148 $4.4461 Acquired 1148 Direct
2013-09-30 Common Stock S 1148 $22.22 Disposed 0 Direct
2013-09-30 Common Stock M 2352 $4.4461 Acquired 2352 Direct
2013-09-30 Common Stock S 2352 $22.22 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-09-30 Employee Stock Option (Right to Buy) $4.4461 M 1148 Disposed 2018-04-23 Common Stock (1148) Direct
2013-09-30 Employee Stock Option (Right to Buy) $4.4461 M 2352 Disposed 2018-04-23 Common Stock (2352) Direct

Footnotes

F1: The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2013.

F2: The shares subject to the Option fully vested on March 31, 2012.

F3: The shares subject to the Option fully vested on May 1, 2012.